Karo Healthcare’s Acquisition of Lamisil from Haleon for £235M

Allen & Overy advised Haleon plc on divestiture of Lamisil.Haleon plc effectively sold its Lamisil brand across more than 70 jurisdictions to Karo Healthcare AB, securing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Georgio Naffaa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here